CRISPR Therapeutics AG Common Stock is a security (CUSIP H17182108) tracked across SEC portfolio filings. 528 institutional managers reported $3.7B on Form 13F as of 2026-06-30; 5 registered fund positions totaling $80.2M via N-PORT as of 2026-05-31.
Showing 15 of 528 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| ARK Investment Management LLC | St. Petersburg, FL | $538.2M | 11,313,623 |
| BlackRock, Inc. | New York, NY | $365.3M | 7,680,073 |
| Orbis Allan Gray Ltd | HamiltoN, D0 | $290.5M | 6,106,011 |
| Capital World Investors | LOS ANGELES, CA | $224.8M | 4,725,037 |
| STATE STREET CORP | BOSTON, MA | $189.4M | 3,982,500 |
| GSK plc | London, X0 | $153.2M | 3,220,627 |
| VANGUARD GROUP INC | Valley Forge, PA | $119.0M | 2,268,394 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $113.1M | 2,377,164 |
| SR ONE CAPITAL MANAGEMENT, LP | WAYNE, PA | $97.0M | 2,038,763 |
| Sumitomo Mitsui Trust Group, Inc. | CHIYODA-KU, TOKYO, M0 | $93.8M | 1,720,734 |
| FMR LLC | BOSTON, MA | $93.0M | 1,954,694 |
| Nikko Asset Management Americas, Inc. | New York, NY | $88.2M | 1,853,875 |
| UBS Group AG | Zurich, V8 | $83.8M | 1,762,530 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | BALA CYNWYD, PA | $78.4M | 593,406 |
| TWO SIGMA INVESTMENTS, LP | New York, NY | $70.5M | 1,483,051 |
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $51.0M | 6.26% |
| VANGUARD RUSSELL 2000 INDEX FUND | VANGUARD SCOTTSDALE FUNDS | $26.4M | 15.04% |
| Clough Global Equity Fund | CLOUGH GLOBAL EQUITY FUND | $2.2M | 124.54% |
| Clough Global Long/Short Fund | CLOUGH GLOBAL LONG/SHORT FUND | $621K | 213.32% |
| TIAA Separate Account VA-1 - Stock Index Account | TIAA Separate Account VA-1 | $85K | 0.66% |